Natixis Advisors LLC boosted its stake in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 33.0% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 273,226 shares of the real estate investment trust's stock after purchasing an additional 67,830 shares during the quarter. Natixis Advisors LLC's holdings in Healthpeak Properties were worth $5,525,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds have also bought and sold shares of DOC. Fuller & Thaler Asset Management Inc. lifted its holdings in shares of Healthpeak Properties by 10.6% in the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 17,267,917 shares of the real estate investment trust's stock worth $350,021,000 after acquiring an additional 1,651,235 shares during the last quarter. Northern Trust Corp raised its position in Healthpeak Properties by 32.6% in the 4th quarter. Northern Trust Corp now owns 10,526,223 shares of the real estate investment trust's stock worth $213,367,000 after purchasing an additional 2,590,530 shares during the period. Nuveen Asset Management LLC lifted its stake in Healthpeak Properties by 5.4% in the fourth quarter. Nuveen Asset Management LLC now owns 7,400,886 shares of the real estate investment trust's stock worth $150,016,000 after purchasing an additional 379,745 shares during the last quarter. Ameriprise Financial Inc. lifted its stake in Healthpeak Properties by 15.6% in the fourth quarter. Ameriprise Financial Inc. now owns 6,671,491 shares of the real estate investment trust's stock worth $134,028,000 after purchasing an additional 902,171 shares during the last quarter. Finally, Resolution Capital Ltd purchased a new stake in Healthpeak Properties during the fourth quarter valued at about $122,795,000. 93.57% of the stock is currently owned by institutional investors.
Insider Activity at Healthpeak Properties
In other news, Director Tommy G. Thompson acquired 5,777 shares of the firm's stock in a transaction on Wednesday, May 28th. The stock was acquired at an average price of $17.27 per share, for a total transaction of $99,768.79. Following the completion of the acquisition, the director owned 144,290 shares in the company, valued at $2,491,888.30. This trade represents a 4.17% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Scott M. Brinker acquired 1,490 shares of the stock in a transaction on Monday, August 4th. The shares were purchased at an average cost of $16.83 per share, with a total value of $25,076.70. Following the transaction, the chief executive officer directly owned 211,906 shares of the company's stock, valued at approximately $3,566,377.98. This trade represents a 0.71% increase in their position. The disclosure for this purchase can be found here. Insiders have purchased 23,010 shares of company stock worth $396,673 over the last 90 days. 0.23% of the stock is currently owned by corporate insiders.
Wall Street Analysts Forecast Growth
DOC has been the topic of several analyst reports. Scotiabank downgraded Healthpeak Properties from a "sector outperform" rating to a "sector perform" rating and decreased their price objective for the stock from $21.00 to $19.00 in a report on Tuesday, July 29th. Wells Fargo & Company reduced their price target on Healthpeak Properties from $22.00 to $20.00 and set an "equal weight" rating on the stock in a research report on Monday, June 2nd. Robert W. Baird set a $21.00 price objective on Healthpeak Properties and gave the company an "outperform" rating in a research report on Wednesday, July 30th. Argus reissued a "buy" rating and set a $25.00 price objective on shares of Healthpeak Properties in a research note on Tuesday, April 29th. Finally, Wall Street Zen downgraded shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a research note on Monday, July 7th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat.com, Healthpeak Properties currently has a consensus rating of "Moderate Buy" and a consensus price target of $23.00.
Get Our Latest Stock Analysis on Healthpeak Properties
Healthpeak Properties Trading Up 0.6%
Healthpeak Properties stock traded up $0.10 during mid-day trading on Thursday, reaching $16.95. 4,853,953 shares of the company traded hands, compared to its average volume of 7,956,932. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.28 and a quick ratio of 1.28. Healthpeak Properties, Inc. has a 52-week low of $16.64 and a 52-week high of $23.26. The firm has a market capitalization of $11.78 billion, a price-to-earnings ratio of 9.21, a P/E/G ratio of 2.15 and a beta of 1.05. The firm's 50 day moving average price is $17.66 and its 200 day moving average price is $18.64.
Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its quarterly earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.46. Healthpeak Properties had a net margin of 5.90% and a return on equity of 1.85%. The company had revenue of $694.35 million for the quarter, compared to analysts' expectations of $697.14 million. During the same quarter in the previous year, the company earned $0.45 earnings per share. Healthpeak Properties's quarterly revenue was down .2% on a year-over-year basis. On average, analysts anticipate that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.
Healthpeak Properties Announces Dividend
The company also recently announced a monthly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Friday, September 19th will be paid a $0.1017 dividend. This represents a c) dividend on an annualized basis and a dividend yield of 7.2%. The ex-dividend date is Friday, September 19th. Healthpeak Properties's dividend payout ratio (DPR) is presently 508.33%.
Healthpeak Properties Profile
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Further Reading

Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report